SETD2 detection may reveal response to induction therapy and survival profile in acute myeloid leukemia patients.
Sign Up to like & getrecommendations! Published in 2023 at "Hematology"
DOI: 10.1080/16078454.2022.2161194
Abstract: OBJECTIVE SET domain containing protein 2 (SETD2) involves in the progression and development of chemotherapy resistance in acute myeloid leukemia (AML). Hence, this study aimed to investigate the relationship of SETD2 expression with disease risk,… read more here.
Keywords: induction therapy; setd2 expression; survival; survival profile ... See more keywords